ABIGAIL CAMERO: Open Payments
NPI 1629772959 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 22 payments from 13 companies in 2025. Trend: 2023 $72 · 2024 $991 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $187 |
| PFIZER INC. | 5 | $89 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Abbott Laboratories | 1 | $29 |
| Seqirus USA Inc | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: BREZTRI, NURTEC ODT, AIRSUPRA, TRELEGY ELLIPTA, INSPIRE, FREESTYLE LIBRE, Fluad, JARDIANCE.
Industry payments across TX — which companies pay providers there.
